Recommended Protocol for Post-Weight-Loss Skin Tightening Dosage: 2 mg daily subcutaneous injection Cycle length: 10 to 12 weeks Rest period: 4 to 6 weeks between cycles Injection sites: Rotate between abdomen, upper arms, and thighs Optional addition: Topical GHK-Cu serum (0.5 to 1%) applied to problem areas Cycles per year: 2 to 3 Subcutaneous injection is the preferred route for skin applications because it provides near 100% bioavailability and allows for easy self-administration using 29 to 31 gauge insulin syringes at a 45 to 90 degree angle
The peptide's molecular weight of 340 Da allows excellent skin penetration when applied topically, though systemic administration provides broader therapeutic effects
BPC-157 appears to promote controlled angiogenesis in these environments, not the chaotic vessel formation youd worry about in an oncology context, but organized vascular ingrowth that supports matrix remodeling
The vitamin D receptor (VDR) mediates most of vitamin Ds biological effects through genomic mechanisms involving direct DNA binding and gene transcription regulation
A bottle of sublingual B12 costs less than a coffee per month
Foundational mechanism paper